These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20306693)

  • 1. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors.
    Ahmed MI; Hassab HM
    Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble CD44 in pediatric patients with acute leukemia.
    Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
    J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival.
    Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S
    Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
    Amirghofran Z; Asiaee E; Kamazani FM
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
    Ratei R; Basso G; Dworzak M; Gaipa G; Veltroni M; Rhein P; Biondi A; Schrappe M; Ludwig WD; Karawajew L;
    Leukemia; 2009 Mar; 23(3):528-34. PubMed ID: 19020543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer.
    Baek JM; Jin Q; Ensor J; Boulbes DR; Esteva FJ
    Breast Cancer Res Treat; 2011 Dec; 130(3):1029-36. PubMed ID: 21830016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
    Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
    Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt.
    Settin A; Al Haggar M; Al Dosoky T; Al Baz R; Abdelrazik N; Fouda M; Aref S; Al-Tonbary Y
    Hematology; 2007 Apr; 12(2):103-11. PubMed ID: 17454190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
    Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
    Sasaki K; Niitsu N
    Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia].
    Fan JJ; Chai YH; Hu SY; He HL; Zhao WL; Wang Y; Li J; Lu J; Xiao PF; Sun YN; Wang W; Cao L
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):523-6. PubMed ID: 24267134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
    Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
    Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.